Emerging and investigational drugs for premature ejaculation
- PMID: 27652222
- PMCID: PMC5001989
- DOI: 10.21037/tau.2016.04.02
Emerging and investigational drugs for premature ejaculation
Abstract
Over the past 20-30 years, the premature ejaculation (PE) treatment paradigm, previously limited to behavioural psychotherapy, has expanded to include drug treatment. Pharmacotherapy for PE predominantly targets the multiple neurotransmitters and receptors involved in the control of ejaculation which include serotonin, dopamine, oxytocin, norepinephrine, gamma amino-butyric acid (GABA) and nitric oxide (NO). The objective of this article is to review emerging PE interventions contemporary data on the treatment of PE was reviewed and critiqued using the principles of evidence-based medicine. Multiple well-controlled evidence-based studies have demonstrated the efficacy and safety of selective serotonin reuptake inhibitors (SSRIs) in delaying ejaculation, confirming their role as first-line agents for the medical treatment of lifelong and acquired PE. Daily dosing of SSRIs is likely to be associated with superior fold increases in IELT compared to on-demand SSRIs. On-demand SSRIs are less effective but may fulfill the treatment goals of many patients. Integrated pharmacotherapy and CBT may achieve superior treatment outcomes in some patients. PDE-5 inhibitors alone or in combination with SSRIs should be limited to men with acquired PE secondary to co-morbid ED. New on-demand rapid acting SSRIs, oxytocin receptor antagonists, or single agents that target multiple receptors may form the foundation of more effective future on-demand medication. Current evidence confirms the efficacy and safety of dapoxetine, off-label SSRI drugs, tramadol and topical anaesthetics drugs. Treatment with α1-adrenoceptor antagonists cannot be recommended until the results of large well-designed RCTs are published in major international peer-reviewed medical journals. As our understanding of the neurochemical control of ejaculation improves, new therapeutic targets and candidate molecules will be identified which may increase our pharmacotherapeutic armamentarium.
Keywords: Premature ejaculation (PE); investigational; treatment.
Conflict of interest statement
Dr. Mcmahon is or has been a consultant, investigator and speaker for Johnson & Johnson, Janssen Cilag, Menarini, Ixchelsis, Absorption Pharmaceuticals, NeuroHealing and Plethora.
Similar articles
-
Current and Emerging Treatments for Premature Ejaculation.Sex Med Rev. 2015 Jul;3(3):183-202. doi: 10.1002/smrj.49. Epub 2015 Oct 8. Sex Med Rev. 2015. PMID: 27784609 Review.
-
Current and emerging treatment options for premature ejaculation.Nat Rev Urol. 2022 Nov;19(11):659-680. doi: 10.1038/s41585-022-00639-5. Epub 2022 Aug 25. Nat Rev Urol. 2022. PMID: 36008555 Review.
-
Premature ejaculation: definition and drug treatment.Drugs. 2007;67(4):547-68. doi: 10.2165/00003495-200767040-00005. Drugs. 2007. PMID: 17352514 Review.
-
Dapoxetine and the treatment of premature ejaculation.Transl Androl Urol. 2013 Dec;2(4):301-11. doi: 10.3978/j.issn.2223-4683.2013.12.01. Transl Androl Urol. 2013. PMID: 26816743 Free PMC article. Review.
-
Selective serotonin reuptake inhibitors in the treatment of premature ejaculation.Chin Med J (Engl). 2007 Jun 5;120(11):1000-6. Chin Med J (Engl). 2007. PMID: 17624269 Review.
Cited by
-
Mechanism of Shugan Yidan fan, a Chinese herbal formula, in rat model of premature ejaculation.Basic Clin Androl. 2023 Oct 3;33(1):25. doi: 10.1186/s12610-023-00200-3. Basic Clin Androl. 2023. PMID: 37784033 Free PMC article.
-
The Influence of Tramadol on Intravaginal Ejaculatory Latency Time and Sexual Satisfaction Score in Treating Patients With Premature Ejaculation: A Network Meta-Analysis.Am J Mens Health. 2021 Nov-Dec;15(6):15579883211057713. doi: 10.1177/15579883211057713. Am J Mens Health. 2021. PMID: 34911381 Free PMC article.
-
Drosophila Corazonin Neurons as a Hub for Regulating Growth, Stress Responses, Ethanol-Related Behaviors, Copulation Persistence and Sexually Dimorphic Reward Pathways.J Dev Biol. 2021 Jul 5;9(3):26. doi: 10.3390/jdb9030026. J Dev Biol. 2021. PMID: 34287347 Free PMC article. Review.
-
Safety and efficacy of "on-demand" tramadol in patients with premature ejaculation: an updated meta-analysis.Int Braz J Urol. 2021 Sep-Oct;47(5):921-934. doi: 10.1590/S1677-5538.IBJU.2020.0561. Int Braz J Urol. 2021. PMID: 33566469 Free PMC article. Review.
-
A Comparative Study of Yoga with Paroxetine for the Treatment of Premature Ejaculation: A Pilot Study.Int J Yoga. 2020 Sep-Dec;13(3):227-232. doi: 10.4103/ijoy.IJOY_89_19. Epub 2020 Sep 13. Int J Yoga. 2020. PMID: 33343153 Free PMC article.
References
-
- Peroutka SJ, Snyder SH. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 1979;16:687-99. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous